No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr3:22393600-22402200 |
Weak transcription |
Fetal Lung |
lung
|
2 |
chr3:22394600-22398800 |
Weak transcription |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
3 |
chr3:22394800-22398800 |
Weak transcription |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
4 |
chr3:22398800-22399600 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
5 |
chr3:22398800-22399600 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
6 |
chr3:22399400-22400400 |
Enhancers |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
7 |
chr3:22399600-22402400 |
Weak transcription |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
8 |
chr3:22399600-22402600 |
Weak transcription |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
9 |
chr3:22400400-22402600 |
Weak transcription |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
10 |
chr3:22401400-22402800 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
11 |
chr3:22401800-22403200 |
Enhancers |
Adipose Nuclei |
Adipose
|
12 |
chr3:22402200-22402800 |
Enhancers |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
13 |
chr3:22402200-22403000 |
Enhancers |
Fetal Lung |
lung
|
14 |
chr3:22402200-22403200 |
Enhancers |
NHDF-Ad |
bronchial
|
15 |
chr3:22402200-22403400 |
Enhancers |
Pancreatic Islets |
Pancreatic Islet
|
16 |
chr3:22402400-22403000 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
17 |
chr3:22402600-22403000 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
18 |
chr3:22402600-22403000 |
Enhancers |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
19 |
chr3:22402800-22403000 |
Flanking Active TSS |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
20 |
chr3:22402800-22403400 |
Flanking Active TSS |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
21 |
chr3:22403000-22403200 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
22 |
chr3:22403000-22403400 |
Flanking Active TSS |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
23 |
chr3:22403000-22403400 |
Flanking Active TSS |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
24 |
chr3:22403200-22403400 |
Flanking Active TSS |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
25 |
chr3:22403400-22404200 |
Enhancers |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
26 |
chr3:22403400-22406200 |
Weak transcription |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
27 |
chr3:22403400-22406200 |
Weak transcription |
Pancreatic Islets |
Pancreatic Islet
|
28 |
chr3:22403400-22406400 |
Weak transcription |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
29 |
chr3:22406200-22406400 |
Enhancers |
Pancreatic Islets |
Pancreatic Islet
|
30 |
chr3:22406200-22408200 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
31 |
chr3:22406400-22406600 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
32 |
chr3:22406400-22410400 |
Weak transcription |
Pancreatic Islets |
Pancreatic Islet
|
33 |
chr3:22406600-22407000 |
Weak transcription |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
34 |
chr3:22407000-22408400 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
35 |
chr3:22408200-22409400 |
Weak transcription |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
36 |
chr3:22408400-22409400 |
Weak transcription |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
37 |
chr3:22409400-22410400 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
38 |
chr3:22409400-22411000 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
39 |
chr3:22410400-22411600 |
Weak transcription |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
40 |
chr3:22410400-22415200 |
Active TSS |
Pancreatic Islets |
Pancreatic Islet
|
41 |
chr3:22411000-22411400 |
Weak transcription |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
42 |
chr3:22411400-22412400 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
43 |
chr3:22411600-22412200 |
Enhancers |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
44 |
chr3:22411800-22412600 |
Bivalent Enhancer |
Fetal Lung |
lung
|
45 |
chr3:22412000-22412200 |
Bivalent Enhancer |
HUES48 Cell Line |
embryonic stem cell
|
46 |
chr3:22412200-22413400 |
Bivalent Enhancer |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
47 |
chr3:22412200-22415000 |
Flanking Active TSS |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
48 |
chr3:22412400-22412600 |
Bivalent Enhancer |
Adipose Nuclei |
Adipose
|
49 |
chr3:22412400-22415000 |
Flanking Active TSS |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
50 |
chr3:22412600-22412800 |
Flanking Bivalent TSS/Enh |
Fetal Lung |
lung
|